HC Deb 18 January 2001 vol 361 c301W
Dr. Tonge

To ask the Chancellor of the Exchequer what progress has been made with his commitment to increase funds available for vaccine research into HIV/AIDS, malaria and TB for developing countries announced as part of the Comprehensive Spending Review. [145923]

Miss Melanie Johnson

The Government—in consultation with the pharmaceutical industry and other stakeholders—are undertaking an urgent study into what can be done to promote research into vaccines for those diseases that particularly affect developing countries such as HIV/AIDS, malaria and TB. As announced in the pre-Budget report, the Treasury is looking at a range of tax options, focusing on creating the right incentives, as part of a wider review of the response to this global issue co-ordinated by the Performance and Innovation Unit.